Search research articles
Contact Us
Filters
Showing results (401-410 of 410) with videos related to
Page
of 41
Sort By:
You have reached the last page of results.
This site can display upto 410 results.
The Journal of Infectious Diseases
|
May 27, 2010
Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans
Louise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
Lancet (London, England)
|
December 4, 2023
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, et al.
Science Advances
|
February 27, 2026
Host iron deficiency protects against <i>Plasmodium</i> infection and drives parasite molecular reprofiling
Danielle Clucas, Cavan Bennett, Rebecca Harding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, et al.
Gynecologic Oncology
|
April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study
Els Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.
American Journal of Public Health
|
November 15, 2019
Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018
Charles Alpren, Erica L Dawson, Betsey John, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration
G Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
A du Bois, M Quinn, T Thigpen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Page
of 41
Search research articles
Search
Showing results (401-410 of 410) with videos related to
Sort By:
Page
of 41
You have reached the last page of results.
This site can display upto 410 results.
The Journal of Infectious Diseases
|
May 27, 2010
Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans
Louise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
Lancet (London, England)
|
December 4, 2023
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, et al.
Science Advances
|
February 27, 2026
Host iron deficiency protects against <i>Plasmodium</i> infection and drives parasite molecular reprofiling
Danielle Clucas, Cavan Bennett, Rebecca Harding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, et al.
Gynecologic Oncology
|
April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study
Els Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.
American Journal of Public Health
|
November 15, 2019
Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018
Charles Alpren, Erica L Dawson, Betsey John, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration
G Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
A du Bois, M Quinn, T Thigpen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Page
of 41